StockData
Nuvectis Pharma, Inc. logo

Nuvectis Pharma, Inc. (NVCT) stock

NVCTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 6/30
$19.20+0.09 (+0.47%)

Close on Nov 17, 2026Market cap $625.57MP/E –Yield 0.00%

Nuvectis Pharma price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Nuvectis Pharma's price to book ratio was 61.7× on Nov 11, 2026, against 6.7× a year earlier. Over the last 5 years it ranged from 5.3× to 66.8×, with a median of 10.4×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202661.7×+53.7
2025Dec 31, 20258.1×−1.3
2024Dec 31, 20249.3×+0.7
2023Dec 29, 20238.7×+3.3
2022Dec 30, 20225.4×–

More Nuvectis Pharma figures

See a number that looks wrong?